John Lippelman Md Pa is categorized under Internal Medicine Practitioners in Tampa, FL and active since 1982.
John Lippelman Md Pa was established in 1982, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact John Lippelman at the company’s single location by writing to 2919 West Swann Avenue # 203, Tampa, Florida FL 33609 or by phoning (813) 870-1747. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | John Lippelman Md Pa |
| Contact Person: | John Lippelman |
| Address: | 2919 West Swann Avenue # 203, Tampa, Florida 33609 |
| Phone Number: | (813) 870-1747 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1982 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Practitioners |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
John Lippelman Md Pa was started in 1982 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact John Lippelman for inquiries that concern John Lippelman Md Pa by calling the company number (813) 870-1747, as your correspondence is most welcome. Additionally, the physical location of the single location of John Lippelman Md Pa can be found at the coordinates 27.937587,-82.49077 as well as the street address 2919 West Swann Avenue # 203 in Tampa, Florida 33609.
For its online presence, you may visit John Lippelman Md Pa’s website at and engage with its social media outlets through on Twitter and on Facebook.